APLLTD — Alembic Pharmaceuticals Share Price
0.000.00%
Last trade - 00:00- IN₹244.30bn
- IN₹248.02bn
- IN₹62.29bn
- 98
- 15
- 84
- 78
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 30.9 | ||
| PEG Ratio (f) | 1.85 | ||
| EPS Growth (f) | 20.12% | ||
| Dividend Yield (f) | 0.84% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.07 | ||
| Price to Tang. Book | 5.07 | ||
| Price to Free Cashflow | 51.35 | ||
| Price to Sales | 3.88 | ||
| EV to EBITDA | 25.53 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.95% | ||
| Return on Equity | 13.71% | ||
| Operating Margin | 11.04% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 46,057.5 | 53,931.3 | 53,057.9 | 56,526.2 | 62,286.3 | 68,101.78 | 76,263.16 | 9.62% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +55.22 | +22.97 | -55.21 | -33.42 | +77.24 | +13.9 | +25.25 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.
Directors
- Chirayu Amin CHM (66)
- Rajkumar Baheti CFO (54)
- Ajay Desai SVF
- Charandeep Saluja CCO
- Pranav Amin MDR (46)
- Shaunak Amin MDR
- Ashok Barat IND (65)
- Archana Hingorani IND (56)
- Pranav Parikh NID
- K. Ramanathan NID
- Paresh Saraiya NID
- Last Annual
- March 31st, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- June 16th, 2010
- Public Since
- September 17th, 2011
- No. of Shareholders
- 78,191
- No. of Employees
- 14,858
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 196,563,124
- Address
- Alembic Road, VADODARA, 390003
- Web
- https://alembicpharmaceuticals.com/
- Phone
- +91 2652282550
- Auditors
- K. C. Mehta & Co.
Upcoming Events for APLLTD
Q3 2025 Alembic Pharmaceuticals Ltd Earnings Release
Similar to APLLTD
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Alembic Pharmaceuticals share price?
As of Today at 19:10 UTC, shares in Alembic Pharmaceuticals are trading at IN₹1,242.85. This share price information is delayed by 15 minutes.
How has the Alembic Pharmaceuticals share price performed this year?
Shares in Alembic Pharmaceuticals last closed at IN₹1,242.85 and the price had moved by +60.18% over the past 365 days. In terms of relative price strength the Alembic Pharmaceuticals share price has outperformed the S&P BSE 100 Index by +21.09% over the past year.
What are the analyst and broker recommendations for Alembic Pharmaceuticals?
The overall consensus recommendation for Alembic Pharmaceuticals is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Alembic Pharmaceuticals dividend yield?
The Alembic Pharmaceuticals dividend yield is 0.89% based on the trailing twelve month period.
Does Alembic Pharmaceuticals pay a dividend?
Last year, Alembic Pharmaceuticals paid a total dividend of IN₹11.00, and it currently has a trailing dividend yield of 0.89%. We do not have any data on when Alembic Pharmaceuticals is to next pay dividends.
When does Alembic Pharmaceuticals next pay dividends?
We do not have data on when Alembic Pharmaceuticals is to next pay dividends. The historic dividend yield on Alembic Pharmaceuticals shares is currently 0.89%.
How do I buy Alembic Pharmaceuticals shares?
To buy shares in Alembic Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Alembic Pharmaceuticals?
As of the previous close price of IN₹1,242.85, shares in Alembic Pharmaceuticals had a market capitalisation of IN₹244.30bn.
Where are Alembic Pharmaceuticals shares listed?
Here are the trading details for Alembic Pharmaceuticals:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: APLLTD
What kind of share is Alembic Pharmaceuticals?
Based on an overall assessment of its quality, value and momentum Alembic Pharmaceuticals is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Alembic Pharmaceuticals share price forecast for 2024?
The analyst consensus target price for shares in Alembic Pharmaceuticals is IN₹1,095.82. That is 11.83% below the last closing price of IN₹1,242.85.
Analysts covering Alembic Pharmaceuticals currently have a consensus Earnings Per Share (EPS) forecast of IN₹35.59 for the next financial year.
Find out moreWhat is the trend in the Alembic Pharmaceuticals share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alembic Pharmaceuticals. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +10.32%.
As of the last closing price of IN₹1,242.85, shares in Alembic Pharmaceuticals were trading +24.42% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Alembic Pharmaceuticals PE Ratio?
The Alembic Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is 30.9. The shares last closed at IN₹1,242.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Alembic Pharmaceuticals?
Alembic Pharmaceuticals' management team is headed by:
- Chirayu Amin - CHM
- Rajkumar Baheti - CFO
- Ajay Desai - SVF
- Charandeep Saluja - CCO
- Pranav Amin - MDR
- Shaunak Amin - MDR
- Ashok Barat - IND
- Archana Hingorani - IND
- Pranav Parikh - NID
- K. Ramanathan - NID
- Paresh Saraiya - NID